Murphy Shannon K, Pike Madeline R, Lipner Emily, Maxwell Seth D, Cohn Barbara A, Cirillo Piera, Krigbaum Nickilou Y, Breen Elizabeth C, Ellman Lauren M
Temple University, Department of Psychology & Neuroscience, Philadelphia, PA, USA.
Child Health and Development Studies, Public Health Institute, Oakland, CA, USA.
Brain Behav Immun Health. 2024 Oct 16;42:100892. doi: 10.1016/j.bbih.2024.100892. eCollection 2024 Dec.
To determine if maternal prenatal infection increases risk of offspring postnatal infections through age 5 or diagnosis of respiratory allergy at age 5, independent of prenatal/postnatal antibiotic exposure. To evaluate if frequency of offspring infections mediates an association between prenatal infection and respiratory allergy at age 5.
Secondary data analyses were performed from the Child Health and Development Studies (CHDS), a prospective, longitudinal birth cohort that enrolled pregnant women from 1959 to 1966 (N = 19,044 live births). The sample included a subset of mother-offspring dyads ( = 2062) with abstracted medical record data from the prenatal period through age 5 that included information on antibiotic use, infection, and offspring respiratory allergy.
Second trimester maternal infection was associated with an increased risk of offspring infection (IRR = 1.23; 95% CI = 1.09-1.39; = 0.001). No significant direct associations were detected between prenatal infection and diagnosis of offspring respiratory allergy. Offspring infection (OR = 1.17; 95% CI = 1.13-1.20; < 0.001) and antibiotic exposure (OR = 1.28; 95% CI = 1.22-1.33; < 0.001) were significantly associated with a diagnosis of offspring respiratory allergy. Respiratory allergy diagnosis risk was greater with increasing offspring infection exposure and antibiotics. There was a significant indirect effect of second trimester maternal infection on offspring respiratory allergy, due to infections and not antibiotic use, via offspring infection, indicating a partially mediated effect.
Prenatal maternal infection may contribute to increase risk for early childhood infections, which in turn, may increase risk for allergic conditions.
确定孕产妇产前感染是否会增加子代5岁前发生产后感染的风险或5岁时诊断为呼吸道过敏的风险,且独立于产前/产后抗生素暴露情况。评估子代感染频率是否介导产前感染与5岁时呼吸道过敏之间的关联。
对儿童健康与发展研究(CHDS)进行二次数据分析,这是一项前瞻性纵向出生队列研究,纳入了1959年至1966年的孕妇(N = 19,044例活产)。样本包括一组母婴二元组(n = 2062),其具有从孕期到5岁的医学记录数据摘要,包括抗生素使用、感染和子代呼吸道过敏信息。
孕中期孕产妇感染与子代感染风险增加相关(发病率比值比[IRR] = 1.23;95%置信区间[CI] = 1.09 - 1.39;P = 0.001)。未检测到产前感染与子代呼吸道过敏诊断之间存在显著直接关联。子代感染(比值比[OR] = 1.17;95% CI = 1.13 - 1.20;P < 0.001)和抗生素暴露(OR = 1.28;95% CI = 1.22 - 1.33;P < 0.001)与子代呼吸道过敏诊断显著相关。随着子代感染暴露和抗生素使用增加,呼吸道过敏诊断风险更高。孕中期孕产妇感染通过子代感染对子代呼吸道过敏有显著间接影响,是由于感染而非抗生素使用,表明存在部分介导效应。
产前孕产妇感染可能导致幼儿感染风险增加,进而可能增加过敏疾病风险。